Hepatitis C

Hepatitis C is a blood-borne virus that infects the liver, where it causes significant inflammation, damage and disruption of normal liver function. According to estimates by the World Health Organization, around 3 to 4 million people worldwide are infected with hepatitis C every year.
What is Hepatitis C?

Hepatitis C infection is a liver infection caused by the Hepatitis C virus. Infection with hepatitis C may damage the liver leading to chronic infection.

Read More

Overview

Feature Articles

Latest Hepatitis C News and Research

Health care groups dive into property tax ballot fight, eyeing public health money

Health care groups dive into property tax ballot fight, eyeing public health money

WHO study finds Remdesivir and other repurposed drugs ineffective in COVID-19

WHO study finds Remdesivir and other repurposed drugs ineffective in COVID-19

Start-up receives NIH grant to accelerate development of contrast agent to detect liver fibrosis

Start-up receives NIH grant to accelerate development of contrast agent to detect liver fibrosis

Researchers receive $1.35 million grant to reduce impact of substance abuse in Appalachia

Researchers receive $1.35 million grant to reduce impact of substance abuse in Appalachia

SHEA releases updated guidance for healthcare workers with HIV, hepatitis

SHEA releases updated guidance for healthcare workers with HIV, hepatitis

Researchers receive €2.35 million to examine disease pathways of viruses

Researchers receive €2.35 million to examine disease pathways of viruses

Case report of arthritis in a COVID-19 patient

Case report of arthritis in a COVID-19 patient

Sofosbuvir combined with other antivirals is more effective against COVID-19, shows study

Sofosbuvir combined with other antivirals is more effective against COVID-19, shows study

Discovery of high affinity binders for SARS-CoV-2 spike protein

Discovery of high affinity binders for SARS-CoV-2 spike protein

Parkinson's disease diagnosed after SARS-CoV-2

Parkinson's disease diagnosed after SARS-CoV-2

New drug candidate suppresses SARS-CoV-2 replication

New drug candidate suppresses SARS-CoV-2 replication

Azelastine antihistamine inhibits SARS-CoV-2 infection in nasal tissue in vitro

Azelastine antihistamine inhibits SARS-CoV-2 infection in nasal tissue in vitro

Study investigates the outcomes of heart transplants from severely obese donors

Study investigates the outcomes of heart transplants from severely obese donors

UTEP's MARC receives federal grant to fight opioid abuse in West Texas rural counties

UTEP's MARC receives federal grant to fight opioid abuse in West Texas rural counties

New book gives overview of viruses and how they emerge to cause pandemics

New book gives overview of viruses and how they emerge to cause pandemics

Personalized determination of genetic factors may improve treatment for polycythaemia vera

Personalized determination of genetic factors may improve treatment for polycythaemia vera

New method offers hope to patients in critical need of kidney transplant

New method offers hope to patients in critical need of kidney transplant

14 existing drugs identified as SARS-CoV-2 main protease inhibitors

14 existing drugs identified as SARS-CoV-2 main protease inhibitors

Evaluating the use of sofosbuvir and daclatasvir for treatment of COVID-19

Evaluating the use of sofosbuvir and daclatasvir for treatment of COVID-19

Whey protein from human breastmilk inhibits SARS-CoV-2 infection

Whey protein from human breastmilk inhibits SARS-CoV-2 infection